74138-29-7

Upstream product

• 137-64-4 2-chloro-5-(chlorosulfonyl)benzoic acid 
• 75-04-7 ethylamine 

Downstream Products

• 74138-35-5 2-Amino-5-ethylsulfamoyl-benzoic acid 
• 90870-01-2 2-Chloro-5-(ethyl-methyl-sulfamoyl)-benzoic acid 
• 90874-18-3 2-Amino-5-ethylsulfamoyl-benzoic acid methyl ester 
• 16668-58-9 4-Amino-N-ethyl-3-hydrazinocarbonyl-N-methyl-benzenesulfonamide 
• 91431-10-6 2-Amino-5-(ethyl-methyl-sulfamoyl)-benzoic acid methyl ester 
• 90874-17-2 2-Amino-5-(ethyl-methyl-sulfamoyl)-benzoic acid 

Relevant academic research and scientific papers

1- (2-AMINO-BENZOL) -PIPERAZINE DERIVATIVES AS GLYCINE UPTAKE INHIBITORS FOR THE TREATMENT OF PSYCHOSES

A compound of formula (I) wherein the substituents are described in claim 1 for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.

CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS

The present invention relates to compounds of formula (I) or pharmaceutically acceptable derivatives thereof, useful in the treatment or prophylaxis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).